Quinnova Pharmaceuticals


“Quinnova Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercial sale of prescription drug products based on innovative dermal drug delivery platforms. Quinnova employs a “reformulation strategy” whereby already-proven safe and effective pharmaceutical ingredients are delivered in unique, effective, convenient, cosmetically elegant and patent protected delivery systems. By employing this “reformulation strategy,” Quinnova is able to bring revenue-generating prescription products to the commercial market on a relatively short development timeline. Quinnova’s portfolio of versatile drug delivery systems lends itself to corporate partnering opportunities beyond the prescription products Quinnova develops in-house. ”

(Source Quinnova)


Date Type Amount Investors Valuation
11/01/06 Series A 13.6M H.I.G. Capital, Thomas, McNerney & Partners Unknown


Lincoln Krochmal (Board Member)

Alex Zisson (Board Member)

Jeffrey S. Day (President)

Christopher S. Brennan (EVP Operations & General Counsel)

G. Frits Besselaar (Board Member)

View more details about all 8 people at Quinnova Pharmaceuticals